NEW DELHI: For British multinational GlaxoSmithKline Consumer Healthcare (GSKCH), India has now become the largest contributor to its global revenues, leading all emerging markets, including China, Middle East and Africa. After tasting success with its most recent venture into the oral healthcare segment in the country, the company is now pulling out all stops to boost growth by way of increasing reach and launching new products.
“The Indian unit has been growing extremely well… India contributed most to GSKCH’s global growth in 2012,” said Jayant Singh, executive vice-president-marketing, GSKCH.
While in India the company has largely been synonymous with its umbrella brand Horlicks, the maker of Boost, Iodex and Eno says the phenomenon is now changing. In the oral healthcare category, for instance, the company has already overtaken Colgate in the sensitive toothpaste segment with its brand Sensodyne in less than two years in modern retail outlets and pharmacies.
Article brought to you by